BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31587024)

  • 1. Cardiac amyloidosis. Two main subtypes and diagnosis by Nuclear Medicine: SPET tracer revival.
    Valsamaki PN; Zissimopoulos A
    Hell J Nucl Med; 2019; 22(3):161-164. PubMed ID: 31587024
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal myocardial perfusion abnormalities in cardiac amyloidosis as compared with CMR, bone scintigraphy, and
    Ensako T; Norikane T; Yamamoto Y; Takami Y; Mitamura K; Maeda Y; Noma T; Nishiyama Y
    J Nucl Cardiol; 2021 Oct; 28(5):2408-2411. PubMed ID: 32909242
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-invasive imaging for cardiac amyloidosis - delaying the obvious?
    Brogan A; Ding Y; Pimentel DR; Sam F
    Int J Cardiol; 2014 Dec; 177(2):e87-9. PubMed ID: 25456697
    [No Abstract]   [Full Text] [Related]  

  • 4. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.
    Falk RH; Dorbala S
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):467-9. PubMed ID: 21267559
    [No Abstract]   [Full Text] [Related]  

  • 5. Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis.
    Kodama K; Hamada M; Kuwahara T; Nakamura M; Shigematsu Y; Hiwada K; Iwata T; Hoshii Y; Ishihara T
    Int J Card Imaging; 1999 Oct; 15(5):371-8. PubMed ID: 10595403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.
    Koutelou M; Prassopoulos V; Lamprakos L; Zissimopoulos A; Chatzipanagiotou T; Mastorakou A; Doumas A
    Hell J Nucl Med; 2023; 26(3):166-171. PubMed ID: 38085831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis.
    Furukawa K; Ikeda S; Okamura N; Tashiro M; Tomita N; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
    Circulation; 2012 Jan; 125(3):556-7. PubMed ID: 22271849
    [No Abstract]   [Full Text] [Related]  

  • 8. Relevance of PET/SPET tracers for cardiac neurotransmission.
    Voipio-Pulkki LM
    Nucl Med Biol; 1995 Nov; 22(8):1027-35. PubMed ID: 8998462
    [No Abstract]   [Full Text] [Related]  

  • 9. Nuclear imaging for cardiac amyloidosis.
    Noordzij W; Glaudemans AW; Longhi S; Slart RH; Lorenzini M; Hazenberg BP; Rapezzi C
    Heart Fail Rev; 2015 Mar; 20(2):145-54. PubMed ID: 25424887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Amyloidosis Detected Using
    García-González P; Cozar-Santiago MDP; Maceira AM
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1215. PubMed ID: 27178118
    [No Abstract]   [Full Text] [Related]  

  • 11. Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.
    Syrota A; Jehenson P
    Eur J Nucl Med; 1991; 18(11):897-923. PubMed ID: 1661237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters.
    Almeida P; Bendriem B; de Dreuille O; Peltier A; Perrot C; Brulon V
    Eur J Nucl Med; 1998 Oct; 25(10):1435-41. PubMed ID: 9818285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
    Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
    Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear cardiology: will we need it in the future?].
    Sechtem U
    Dtsch Med Wochenschr; 2004 Mar; 129(13):693-6. PubMed ID: 15026966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nuclear medicine: state of the art].
    Fazio F
    Radiol Med; 1995 Nov; 90(5):613-5. PubMed ID: 8685433
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of nuclear cardiology in Japan.
    Nishimura T
    J Nucl Cardiol; 1996; 3(5):422-7. PubMed ID: 8902675
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac amyloidosis imaged by dual-source computed tomography.
    Marwan M; Pflederer T; Ropers D; Schmid M; Wasmeier G; Söder S; Daniel WG; Achenbach S
    J Cardiovasc Comput Tomogr; 2008 Nov; 2(6):403-5. PubMed ID: 19083986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in nuclear cardiology.
    Gutte H; Leth Petersen C; Kjaer A; Hesse B
    Panminerva Med; 2008 Jun; 50(2):105-18. PubMed ID: 18607334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear cardiology. Indications for its use].
    Fehér J
    Arq Bras Cardiol; 1994 Jun; 62(6):379-81. PubMed ID: 7826226
    [No Abstract]   [Full Text] [Related]  

  • 20. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
    Dietemann S; Nkoulou R
    Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.